The serious, progressive kidney disease affects nearly 850 million people worldwide
Category: Boehringer Ingelheim
The £30m ADVANCE study is the most extensive study into liver disease worldwide
The serious, progressive kidney disease affects nearly 850 million people worldwide
The £30m ADVANCE study is the most extensive study into liver disease worldwide